NDC 70518-4532-01 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-4532
- Requested NDC
- 70518-4532-01
- Package NDCs from labels
- 70518-4532-1, 70518-4532-0, 70518-4532-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-10-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-10-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-4532-0 | Gabapentin | 100 in 1 BOX | TABLET, FILM COATED | 100 | 1 | |
| 70518-4532-1 | Gabapentin | 1 in 1 POUCH | TABLET, FILM COATED | 1 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| gabapentin | GABAPENTIN | Zydus Lifesciences Limited | 8c0eeefc-ef5b-49f4-8411-ddbae312ed05 | 2025-09-15 | 6CW7F3G59X | |
| GABAPENTIN | GABAPENTIN | MARKSANS PHARMA LIMITED | 98bb408d-c402-4da6-8f9d-5de4833dedc4 | 2025-09-12 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Epic Pharma, LLC | d592d828-8df1-480d-b179-bb9260a9c824 | 2025-09-12 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Zydus Pharmaceuticals USA Inc. | 310ce005-5a24-489a-b23c-d42ab6a3bfed | 2025-09-08 | Warnings, Adverse reactions | 310433 310434 6CW7F3G59X |
| gabapentin | GABAPENTIN | Zydus Pharmaceuticals USA Inc. | 3cfd04ab-e421-441f-a10e-e4dd1412974d | 2025-09-05 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Rising Pharma Holdings, Inc. | b1a9808d-31a5-4b63-afd0-d96d5a0ad7a1 | 2025-09-03 | Warnings, Adverse reactions | 310433 310434 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Mullan Pharmaceutical Inc. | 74474aa4-4859-42d2-92d8-f23f18b34e04 | 2025-08-21 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Direct_Rx | 2cb1ad6d-d389-4564-e063-6394a90a3644 | 2025-08-19 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 137b2b9a-9d42-48d0-913f-5dc146fb689a | 2025-08-19 | Warnings, Adverse reactions | 310433 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Camber Pharmaceuticals, Inc. | 9ead7825-d11b-4e00-8533-328d097b8f83 | 2025-08-16 | Warnings, Adverse reactions | 310433 310434 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Exelan Pharmaceuticals, Inc. | a88edb00-2189-4c8d-9dd7-9fe1571775cc | 2025-08-16 | Warnings, Adverse reactions | 310433 310434 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | XLCare Pharmaceuticals, Inc. | 707ed63a-67ca-4a62-9cbe-cdeb5c4ab506 | 2025-08-16 | Warnings, Adverse reactions | 310433 310434 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | XLCare Pharmaceuticals, Inc. | 618c948d-deee-44e2-98f0-e5232171dd50 | 2025-08-04 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | ca8177ed-1f0d-436e-a5ac-f58b8f7cbb25 | 2025-07-28 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 2278ce1b-1c19-4ad2-89c6-4530f7b78ea7 | 2025-07-14 | Warnings, Adverse reactions | 310434 6CW7F3G59X |
| Gabapentin | GABAPENTIN | NorthStar Rx LLC | 9508cb1b-3f9f-48bd-8f34-a6fbb68c9a4a | 2025-07-11 | Warnings, Adverse reactions | 310433 310434 6CW7F3G59X |
| gabapentin | GABAPENTIN | ScieGen Pharmaceuticals, Inc. | 3f2e3ac5-5233-fd57-e063-6294a90a849e | 2025-07-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | PD-Rx Pharmaceuticals, Inc. | 7c3b232a-3e9f-4249-9e5a-295482ee288a | 2025-06-27 | Warnings, Adverse reactions | 310433 6CW7F3G59X |
| Gabapentin | GABAPENTIN | NorthStar Rx LLC | f7c1fd34-d615-43a2-8989-898fe11f90df | 2025-06-25 | Warnings, Adverse reactions | 6CW7F3G59X |
| Steritalc 2g | TALC | Novatech SA | c94e51d9-beef-4b06-e053-2a95a90a754a | 2025-06-25 | Warnings, Adverse reactions | 7SEV7J4R1U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.